Logo image of ATEX

ANTERIX INC (ATEX) Stock Fundamental Analysis

NASDAQ:ATEX - Nasdaq - US03676C1009 - Common Stock - Currency: USD

28.16  +0.17 (+0.61%)

Fundamental Rating

3

ATEX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 33 industry peers in the Diversified Telecommunication Services industry. While ATEX seems to be doing ok healthwise, there are quite some concerns on its profitability. ATEX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ATEX has reported negative net income.
ATEX had a negative operating cash flow in the past year.
In the past 5 years ATEX always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ATEX reported negative operating cash flow in multiple years.
ATEX Yearly Net Income VS EBIT VS OCF VS FCFATEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

The Return On Assets of ATEX (-9.18%) is worse than 84.85% of its industry peers.
ATEX has a worse Return On Equity (-20.72%) than 72.73% of its industry peers.
Industry RankSector Rank
ROA -9.18%
ROE -20.72%
ROIC N/A
ROA(3y)-7.39%
ROA(5y)-11.55%
ROE(3y)-11.63%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ATEX Yearly ROA, ROE, ROICATEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

ATEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATEX Yearly Profit, Operating, Gross MarginsATEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K

6

2. Health

2.1 Basic Checks

ATEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATEX has less shares outstanding
ATEX has more shares outstanding than it did 5 years ago.
ATEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ATEX Yearly Shares OutstandingATEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ATEX Yearly Total Debt VS Total AssetsATEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.43, we must say that ATEX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.43, ATEX is doing worse than 84.85% of the companies in the same industry.
There is no outstanding debt for ATEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.43
ROIC/WACCN/A
WACC9.12%
ATEX Yearly LT Debt VS Equity VS FCFATEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 1.65 indicates that ATEX should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.65, ATEX belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
A Quick Ratio of 1.65 indicates that ATEX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.65, ATEX belongs to the top of the industry, outperforming 84.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
ATEX Yearly Current Assets VS Current LiabilitesATEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

The earnings per share for ATEX have decreased strongly by -454.35% in the last year.
The Revenue has grown by 66.68% in the past year. This is a very strong growth!
Measured over the past years, ATEX shows a decrease in Revenue. The Revenue has been decreasing by -8.40% on average per year.
EPS 1Y (TTM)-454.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1950%
Revenue 1Y (TTM)66.68%
Revenue growth 3Y65.77%
Revenue growth 5Y-8.4%
Sales Q2Q%23.21%

3.2 Future

The Earnings Per Share is expected to decrease by -22.81% on average over the next years. This is quite bad
The Revenue is expected to grow by 30.56% on average over the next years. This is a very strong growth
EPS Next Y-82.11%
EPS Next 2Y4%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue Next Year36.61%
Revenue Next 2Y18.53%
Revenue Next 3Y30.56%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ATEX Yearly Revenue VS EstimatesATEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ATEX Yearly EPS VS EstimatesATEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEX Price Earnings VS Forward Price EarningsATEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEX Per share dataATEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

ATEX's earnings are expected to decrease with -22.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4%
EPS Next 3Y-22.81%

0

5. Dividend

5.1 Amount

No dividends for ATEX!.
Industry RankSector Rank
Dividend Yield N/A

ANTERIX INC

NASDAQ:ATEX (5/22/2025, 12:16:36 PM)

28.16

+0.17 (+0.61%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)06-11 2025-06-11/amc
Inst Owners86.5%
Inst Owner Change4.82%
Ins Owners1.73%
Ins Owner Change2.55%
Market Cap523.49M
Analysts82.22
Price Target89.25 (216.94%)
Short Float %4.31%
Short Ratio5.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)78.24%
Min EPS beat(2)-14.66%
Max EPS beat(2)171.14%
EPS beat(4)1
Avg EPS beat(4)13.25%
Min EPS beat(4)-83.01%
Max EPS beat(4)171.14%
EPS beat(8)5
Avg EPS beat(8)63.41%
EPS beat(12)7
Avg EPS beat(12)16.89%
EPS beat(16)9
Avg EPS beat(16)12.85%
Revenue beat(2)0
Avg Revenue beat(2)-13.83%
Min Revenue beat(2)-14.71%
Max Revenue beat(2)-12.96%
Revenue beat(4)0
Avg Revenue beat(4)-16.2%
Min Revenue beat(4)-32.26%
Max Revenue beat(4)-4.87%
Revenue beat(8)1
Avg Revenue beat(8)-18.35%
Revenue beat(12)2
Avg Revenue beat(12)-13.91%
Revenue beat(16)4
Avg Revenue beat(16)-13.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.98%
EPS NY rev (1m)0%
EPS NY rev (3m)22.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 88.7
P/FCF N/A
P/OCF N/A
P/B 3.62
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.63
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0.32
BVpS7.79
TBVpS-5.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.18%
ROE -20.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.39%
ROA(5y)-11.55%
ROE(3y)-11.63%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2250.98%
Cap/Sales 252.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z -0.43
F-Score4
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)1951.72%
Cap/Depr(5y)1293.44%
Cap/Sales(3y)1454.89%
Cap/Sales(5y)1277.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-454.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1950%
EPS Next Y-82.11%
EPS Next 2Y4%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue 1Y (TTM)66.68%
Revenue growth 3Y65.77%
Revenue growth 5Y-8.4%
Sales Q2Q%23.21%
Revenue Next Year36.61%
Revenue Next 2Y18.53%
Revenue Next 3Y30.56%
Revenue Next 5YN/A
EBIT growth 1Y4.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-503.81%
EBIT Next 3Y-55.59%
EBIT Next 5YN/A
FCF growth 1Y63.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.38%
OCF growth 3YN/A
OCF growth 5YN/A